SS Innovations International Inc. (NASDAQ: SSII), a developer of innovative surgical robotic technologies, has been named the winner of the Outstanding Company category at the 2026 Surgical Robotics Industry Awards (SRIA), receiving recognition from the industry organization for its work in developing and commercializing robotic surgery technology (https://ibn.fm/lDfv9). The company was selected over nine other finalists, including several established medical technology companies active in robotic surgery.
The award comes as adoption of the SSi Mantra surgical robotic system continues to expand. More than 11,700 procedures have been completed globally using the platform, and over 2,100 physicians have been trained on the system. The SSi Mantra has received regulatory approvals in 14 countries, supporting the company’s international growth strategy. The system has been used across more than 170 different procedures, demonstrating its versatility across multiple surgical specialties.
For investors, the recognition provides an independent industry endorsement as SS Innovations continues to expand its presence in the rapidly growing global surgical robotics market. The surgical robotics industry has become increasingly competitive as healthcare providers adopt robotic-assisted procedures across multiple specialties and manufacturers seek to expand beyond traditional markets. The award was presented to SS Innovations after the company was selected from a field of finalists.
The latest news and updates relating to SSII are available in the company’s newsroom at https://ibn.fm/SSII.
This recognition underscores SS Innovations’ progress in commercializing its technology and building a global footprint. With regulatory approvals in 14 countries and a growing base of trained physicians, the company is positioned to capture additional market share as robotic surgery adoption increases worldwide.
